161 related articles for article (PubMed ID: 37858622)
21. Proteomics of post-translational modifications in colorectal cancer: Discovery of new biomarkers.
Zhu G; Jin L; Sun W; Wang S; Liu N
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188735. PubMed ID: 35577141
[TBL] [Abstract][Full Text] [Related]
22. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
23. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma.
Liu D; Wan Y; Qu N; Fu Q; Liang C; Zeng L; Yang Y
Front Public Health; 2022; 10():898270. PubMed ID: 35874989
[TBL] [Abstract][Full Text] [Related]
24. Natural flavonoids alleviate glioblastoma multiforme by regulating long non-coding RNA.
Liu X; Xiao X; Han X; Yao L; Lan W
Biomed Pharmacother; 2023 May; 161():114477. PubMed ID: 36931030
[TBL] [Abstract][Full Text] [Related]
25. Roles of the m
Yuan F; Cai X; Cong Z; Wang Y; Geng Y; Aili Y; Du C; Zhu J; Yang J; Tang C; Zhang A; Zhao S; Ma C
Front Immunol; 2022; 13():798583. PubMed ID: 35558067
[TBL] [Abstract][Full Text] [Related]
26. Glioblastoma multiforme: novel therapeutic targets.
Muir M; Gopakumar S; Traylor J; Lee S; Rao G
Expert Opin Ther Targets; 2020 Jul; 24(7):605-614. PubMed ID: 32394767
[TBL] [Abstract][Full Text] [Related]
27. The Non-N
Xu J; Gao Z; Liu K; Fan Y; Zhang Z; Xue H; Guo X; Zhang P; Deng L; Wang S; Wang H; Wang Q; Zhao R; Li G
Front Immunol; 2021; 12():809808. PubMed ID: 35154083
[TBL] [Abstract][Full Text] [Related]
28. Systems Level Analysis of Histone H3 Post-translational Modifications (PTMs) Reveals Features of PTM Crosstalk in Chromatin Regulation.
Schwämmle V; Sidoli S; Ruminowicz C; Wu X; Lee CF; Helin K; Jensen ON
Mol Cell Proteomics; 2016 Aug; 15(8):2715-29. PubMed ID: 27302890
[TBL] [Abstract][Full Text] [Related]
29. The function of histone methylation and acetylation regulators in GBM pathophysiology.
McCornack C; Woodiwiss T; Hardi A; Yano H; Kim AH
Front Oncol; 2023; 13():1144184. PubMed ID: 37205197
[TBL] [Abstract][Full Text] [Related]
30. Integrating machine learning and bioinformatics analysis to m6A regulator-mediated methylation modification models for predicting glioblastoma patients' prognosis and immunotherapy response.
Li C; Liu W; Liu C; Luo Q; Luo K; Wei C; Li X; Qin J; Zheng C; Lan C; Wei S; Tan R; Chen J; Chen Y; Huang H; Zhang G; Huang H; Wang X
Aging (Albany NY); 2023 May; 15(10):4051-4070. PubMed ID: 37244287
[TBL] [Abstract][Full Text] [Related]
31. Identification of Systems Level Molecular Signatures from Glioblastoma Multiforme Derived Extracellular Vesicles.
Roy N; Gaikwad M; Bhattacharrya DK; Barah P
J Mol Neurosci; 2021 Jun; 71(6):1156-1167. PubMed ID: 33231813
[TBL] [Abstract][Full Text] [Related]
32. A Systematic Review on Posttranslational Modification in Proteins: Feature Construction, Algorithm and Webserver.
Xu Y; Yang Y; Wang Z; Li C; Shao Y
Protein Pept Lett; 2018; 25(9):807-814. PubMed ID: 30255739
[TBL] [Abstract][Full Text] [Related]
33. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment.
Li C; Deng H; Zhou Y; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
Life Sci; 2020 Nov; 261():118486. PubMed ID: 32976881
[TBL] [Abstract][Full Text] [Related]
34. Functional analysis tools for post-translational modification: a post-translational modification database for analysis of proteins and metabolic pathways.
Cruz ER; Nguyen H; Nguyen T; Wallace IS
Plant J; 2019 Sep; 99(5):1003-1013. PubMed ID: 31034103
[TBL] [Abstract][Full Text] [Related]
35. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
36. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
37. The Chromatin-Oxygen Sensor Gene
Drongitis D; Verrillo L; De Marinis P; Orabona P; Caiola A; Turitto G; Alfieri A; Bruscella S; Gentile M; Moriello V; Sannino E; Di Muccio I; Costa V; Miano MG; de Bellis A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142158
[TBL] [Abstract][Full Text] [Related]
38. Melatonin Modulates the Microenvironment of Glioblastoma Multiforme by Targeting Sirtuin 1.
Lai SW; Liu YS; Lu DY; Tsai CF
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31207928
[TBL] [Abstract][Full Text] [Related]
39. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
[TBL] [Abstract][Full Text] [Related]
40. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
